Issa, N., Arbona-Haddad, E., Nevett-Fernandez, A., Prestes, D., Liakos, A., Woolley, A., . . . Marty, F. (2017). Opportunistic Infections (OIs) in Patients with Hematologic Malignancies (HM) Treated with Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study. Open Forum Infect Dis.
Citación estilo ChicagoIssa, Nicolas, et al. "Opportunistic Infections (OIs) in Patients With Hematologic Malignancies (HM) Treated With Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study." Open Forum Infect Dis 2017.
Cita MLAIssa, Nicolas, et al. "Opportunistic Infections (OIs) in Patients With Hematologic Malignancies (HM) Treated With Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study." Open Forum Infect Dis 2017.